The effect of diabetic control on diabetic retinopathy
- PMID: 7607352
- DOI: 10.1038/eye.1993.66
The effect of diabetic control on diabetic retinopathy
Abstract
Poor diabetic control is associated with an increased risk of diabetic retinopathy, and there is a particularly increased risk in insulin-dependent (type 1) patients for the development of proliferative diabetic retinopathy. There is good evidence that hyperperfusion is an important factor in the evolution of diabetic retinopathy. This hyperperfusion is worse in those with poor diabetic control. The increased blood flow associated with high glucose interferes with autoregulation, and this further increases flow, damaging the endothelial lining of the blood vessels and leading to worsening of the retinopathy.
Similar articles
-
Retinal hemorheologic characterization of early-stage diabetic retinopathy using adaptive optics scanning laser ophthalmoscopy.Invest Ophthalmol Vis Sci. 2014 Sep 11;55(12):8513-22. doi: 10.1167/iovs.14-15121. Invest Ophthalmol Vis Sci. 2014. PMID: 25212778
-
Retinal blood flow changes in patients with insulin-dependent diabetes mellitus and no diabetic retinopathy.Invest Ophthalmol Vis Sci. 1996 Apr;37(5):886-97. Invest Ophthalmol Vis Sci. 1996. PMID: 8603873
-
Alterations of retinal capillary blood flow in preclinical retinopathy in subjects with type 2 diabetes.Graefes Arch Clin Exp Ophthalmol. 2003 Mar;241(3):181-6. doi: 10.1007/s00417-002-0520-9. Epub 2003 Feb 7. Graefes Arch Clin Exp Ophthalmol. 2003. PMID: 12644940
-
The retinal blood flow in diabetes.Diabete Metab. 1993 Sep-Oct;19(5):401-4. Diabete Metab. 1993. PMID: 8056118 Review.
-
Impact of blood pressure on diabetic retinopathy.Diabete Metab. 1989;15(5 Pt 2):333-7. Diabete Metab. 1989. PMID: 2693152 Review.
Cited by
-
Effects of saxagliptin on early microvascular changes in patients with type 2 diabetes.Cardiovasc Diabetol. 2014 Jan 14;13:19. doi: 10.1186/1475-2840-13-19. Cardiovasc Diabetol. 2014. PMID: 24423149 Free PMC article. Clinical Trial.
-
Potent Oral Hypoglycemic Agents for Microvascular Complication: Sodium-Glucose Cotransporter 2 Inhibitors for Diabetic Retinopathy.J Diabetes Res. 2018 Dec 5;2018:6807219. doi: 10.1155/2018/6807219. eCollection 2018. J Diabetes Res. 2018. PMID: 30622970 Free PMC article.
-
A randomised study of the impact of the SGLT2 inhibitor dapagliflozin on microvascular and macrovascular circulation.Cardiovasc Diabetol. 2017 Feb 23;16(1):26. doi: 10.1186/s12933-017-0510-1. Cardiovasc Diabetol. 2017. PMID: 28231831 Free PMC article. Clinical Trial.
-
Association between interarm blood pressure differences and diabetic retinopathy in patients with type 2 diabetes.Diab Vasc Dis Res. 2020 Jul-Aug;17(7):1479164120945910. doi: 10.1177/1479164120945910. Diab Vasc Dis Res. 2020. PMID: 32746630 Free PMC article.
-
Effects of sodium-glucose cotransporter-2 inhibitors and dipeptidyl peptidase-4 inhibitors on diabetic retinopathy and its progression: A real-world Korean study.PLoS One. 2019 Oct 28;14(10):e0224549. doi: 10.1371/journal.pone.0224549. eCollection 2019. PLoS One. 2019. PMID: 31658289 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical